Tumor necrosis factor-α induces the aberrant expression of mucus core protein-2 in non-neoplastic biliary epithelial cells via the upregulation of CDX2 in chronic cholangitis

Hepatology Research

Volumn 38, Issue 10, 2008, Pages 1006-1017

  Ikeda, Hiroko ^a   Sasaki, Motoko ^a   Ohira, Shusaku ^b   Ishikawa, Akira ^b   Sato, Yasunori ^a   Harada, Kenichi ^a   Zen, Yoh ^c   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biliary epithelium; CDX2; Chronic cholangitis; Mucus core protein 2; Tumor necrosis factor

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MUCIN 2; TRANSCRIPTION FACTOR CDX2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT STONE; CHOLANGITIS; CHRONIC DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; INTRAHEPATIC BILE DUCT; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

EID: 51349148375     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00361.x     Document Type: Article

References (22)

1. Zen Y, Fujii T, Itatsu K et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 2006; 44: 1333-43.
2. Roessler K, Monig SP, Schneider PM et al. Co-expression of CDX2 and MUC2 in gastric carcinomas: Correlations with clinico-pathological parameters and prognosis. World J Gastroenterol 2005; 11: 3182-8.
3. Eda A, Osawa H, Satoh K et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol 2003; 38: 14-22.
4. Lord RV, Brabender J, Wickramasinghe K et al. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Surgery 2005; 138: 924-31.
5. Nakanuma Y, Yamaguchi K, Ohta G, Terada T. Pathologic features of hepatolithiasis in Japan. Hum Pathol 1988; 19: 1181-6.
6. Sasaki M, Ikeda H, Nakanuma Y. Expression profiles of MUC mucin core protein in the intrahepatic biliary system: Physiological distribution and pathological significance. Acta Histochem Cytochem 2005; 38: 295-303.
7. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 1998; 27: 54-61.
8. Ishikawa A, Sasaki M, Ohira S et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 2004; 84: 629-38.
9. Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 2006; 55: 16-25.
10. Yamamoto H, Bai YQ, Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 2003; 300: 813-18.
11. Ikeda H, Sasaki M, Ishikawa A et al. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest 2007; 87: 559-71.
12. Silberg DG, Sullivan J, Kang E et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002; 122: 689-96.
13. Zen Y, Harada K, Sasaki M et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 2002; 161: 1475-84.
14. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-á in pathologic biliary epithelial cells: In situ and culture study. Lab Invest 1998; 78: 89-100.
15. Harada K, Ohira S, Isse K et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 2003; 83: 1657-67.
16. Sanzen T, Harada K, Yasoshima M, Kawamura Y, Ishibashi M, Nakanuma Y. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis. Am J Pathol 2001; 158: 1605-12.
17. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997; 38: 552-70.
18. Zen Y, Aishima S, Ajioka Y et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int 2005; 55: 180-8.
19. Tabata M, Nakayama F. Bacteriology of hepatolithiasis. Prog Clin Biol Res 1984; 152: 163-74.
20. Ahn DH, Crawley SC, Hokari R et al. TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell Physiol Biochem 2005; 15: 29-40.
21. Busse PJ, Zhang TF, Srivastava K et al. Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo. J Allergy Clin Immunol 2005; 116: 1256-63.
22. Harada K, Sato Y, Itatsu K et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 2007; 46: 1146-54.